Pharmacy

Floraquin Diquinol

Home » Prescription Drugs 8 » Floraquin Diquinol

INDICATIONS:Trichomonas vaginitis monilial vaginitis non-specific and mixed vaginitis.DOSAGE AND DIRECTIONS FOR USE:Two tablets daily inserted high in the vagina before retiring for two or more menstrual cycles. The tablets should be moistened with water before insertion into the vagina. Warm acid douches may be taken as prescribed by the physician or when necessary or desired for hygienic purposes.An applicator is provided to assist correct placement. The importance of personal hygiene is in no way diminished during Floraquin therapy and the presence of vaginal discharge indicates that a sanitary pad should be worn.

Buy Floraquin Diquinol and other Prescription Drugs 8 products online at Medstore.

Buy Online at Medstore - Click Here!

About Floraquin Diquinol:

Product Type: Prescription Drugs 8

Floraquin ( Diquinol Yodoxin Generic di-iodohydroxyquinoline )

Floraquin (Diquinol Yodoxin Generic di-iodohydroxyquinoline)

Diquinol Yodoxin Generic di-iodohydroxyquinoline

100mg 25 Vaginal Tablets 50 Vaginal Tablets 100 Vaginal Tablets Diquinol Yodoxin Generic di-iodohydroxyquinoline Floraquin

View more Prescription Drugs 8

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.